Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.
Autoantibodies identify primary Sjögren’s syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B.
Identification of new candidate drugs for primary Sjögren’s syndrome using a drug repurposing transcriptomic approach.
Author Correction: Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells.
